STANDARD BIOTOOLS INC. (LAB) › Capital ExpendituresSTANDARD BIOTOOLS INC. (LAB) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $799.0K2010: $1.54M2011: $1.68M2012: $2.38M2013: $3.45M2014: $7.40M2015: $3.98M2016: $5.07M2017: $1.57M2018: $372.0K2019: $2.53M2020: $12.72M2021: $13.26M2022: $3.83M2023: $2.83M2024: $8.36M2025: $8.30M$8.30M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$8.30M-0.6%2024$8.36M+195.1%2023$2.83M-26.0%2022$3.83M-71.2%2021$13.26M+4.3%2020$12.72M+402.4%2019$2.53M+580.4%2018$372.0K-76.2%2017$1.57M-69.1%2016$5.07M+27.2%2015$3.98M-46.2%2014$7.40M+114.8%2013$3.45M+44.5%2012$2.38M+42.2%2011$1.68M+8.9%2010$1.54M+92.6%2009$799.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share